CoChat

COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization

Open access
Wu, Yi-Hui, Chang, Tzu-Hao, Huang, Yu-Fang, Chen, Chien-Chin, Chou, Cheng-Yang · 2015 · Oncotarget
Cited by 105

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

// Yi-Hui Wu 1 , Tzu-Hao Chang 2 , Yu-Fang Huang 1 , Chien-Chin Chen 3, 4 , Cheng-Yang Chou 1 1 Department of Obstetrics and Gynaecology, College of Medicine, National Cheng Kung University and Hospital, Tainan, Taiwan 2 Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei, Taiwan 3 Department of Pathology, Chia-Yi Christian Hospital, Chia-Yi, Taiwan 4 Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan Correspondence to: Cheng-Yang Chou, e-mail: chougyn@mail.ncku.edu.tw Keywords: epithelial ovarian carcinoma, chemoresistance, collagen type XI alpha 1, Akt, PDK1 Received: March 27, 2015 Accepted: May 28, 2015 Published: June 10, 2015 ABSTRACT Chemoresistance to anticancer drugs substantially reduces survival in epithelial ovarian carcinoma (EOC). Here, microarray analysis showed that collagen type XI alpha 1 ( COL11A1 ) is a chemotherapy response-associated gene. Chemoresistant cells expressed higher COL11A1 and c/EBPβ than chemosensitive cells. COL11A1 or c/EBPβ downregulation suppressed chemoresistance, whereas COL11A1 overexpression attenuated sensitivity to cisplatin and paclitaxel.The c/EBPβ binding site in the COL11A1 promoter was identified as the major determinant of cisplatin- and paclitaxel-induced COL11A1 expression. Immunoprecipitation and immunofluorescence showed that in resistant cells, Akt and PDK1 were highly expressed and that anticancer drugs enhanced binding activity between COL11A1 and PDK1 binding and attenuated PDK1 ubiquitination and degradation. Conversely, chemosensitive cells showed decreased activity of COL11A1 binding to PDK1 and increased PDK1 ubiquitination, which were reversed by COL11A1 overexpression. Analysis of 104 EOC patients showed that high COL11A1 mRNA levels are significantly associated with poor chemoresponse and clinical outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4250

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 105

Metadata

Authors
Wu, Y.-H., Chang, T.-H., Huang, Y.-F., Chen, C.-C., & Chou, C.-Y.
Venue
Oncotarget
Published
2015-06-10
Volume
6
Issue
27
Pages
23748-23763
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2133201200
Cited by
105
References
5
FWCI
8.19
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization. https://app.cochat.ai/papers/10.18632/oncotarget.4250
The paper
Wu, Y.-H., Chang, T.-H., Huang, Y.-F., Chen, C.-C., & Chou, C.-Y. (2015). COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization. Oncotarget. https://doi.org/10.18632/oncotarget.4250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.